Estrogen and progesterone interactive effects in postconfluent MCF-7 cell culture

Steroids

Volumn 74, Issue 4-5, 2009, Pages 410-418

  Sukocheva, O A ^a   Yang, Y ^b   Gierthy, J F ^b  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Breast cancer; Estrogen; Progesterone; Tropomyosin

Indexed keywords

ALPHA TROPOMYOSIN; ESTRADIOL; ESTROGEN; HORMONE RECEPTOR; PROGESTERONE;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CARCINOGENESIS; CELL ADHESION; CELL DIFFERENTIATION; CELL DIVISION; CELL STIMULATION; CELL STRAIN MCF 7; CYTOSKELETON; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL ADHESION; CELL DIVISION; CELL PROLIFERATION; CELL SHAPE; CYTOSKELETON; DRUG SYNERGISM; ESTROGENS; HUMANS; NEOPLASM PROTEINS; PROGESTERONE; TROPOMYOSIN; TUMOR CELLS, CULTURED;

EID: 61649109244     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2008.12.010     Document Type: Article

References (46)

1. Gierthy J.F., Lincoln D.W., Roth K.E., Bowser S.S., Bennett J.A., Bradley L., et al. Estrogen stimulation of postconfluent cell accumulation and focus formation of human MCF-7 breast cancer cells. J Cell Biochem 45 (1991) 177-187
2. Sukocheva O.A., Yang Y., Gierthy J.F., and Seegal R.F. Methyl mercury influences growth-related signaling in MCF-7 breast cancer cells. Environ Toxicol 20 1 (2005) 32-44
3. DePasquale J.A., Samsonoff W.A., and Gierthy J.F. 17ß-Estradiol induced alterations of cell-matrix and intercellular adhesions in a human mammary carcinoma cell line. J Cell Sci 107 (1994) 1241-1254
4. DePasquale J.A. Rearrangement of the F-actin cytoskeleton in estradiol-treated MCF-7 breast carcinoma cells. Histochem Cell Biol 112 (1999) 341-350
5. Lin J.J., Warren K.S., Wamboldt D.D., Wang T., and Lin J.L. Tropomyosin isoforms in nonmuscle cells. Int Rev Cytol 170 (1997) 1-38
6. O'Neill G.M., Stehn J., and Gunning P.W. Tropomyosins as interpreters of the signalling environment to regulate the local cytoskeleton. Semin Cancer Biol 18 (2008) 35-44
7. Martin S.S., and Leder P. Human MCF10A mammary epithelial cells undergo apoptosis following actin depolymerization that is independent of attachment and rescued by Bcl-2. Mol Cell Biol 21 19 (2001) 6529-6536
8. Giganti A., and Friederich E. The actin cytoskeleton as a therapeutic target: state of the art and future directions. Prog Cell Cycle Res 5 (2003) 511-525
9. Eppinga R.D., Li Y., Lin J.L., and Lin J.J. Tropomyosin and caldesmon regulate cytokinesis speed and membrane stability during cell division. Arch Biochem Biophys 456 2 (2006) 161-174
10. McGowan E.M., Weinberger R.P., Graham J.D., Hill H.D., Hughes J.A., O'Neill G.M., et al. Cytoskeletal responsiveness to progestins is dependent on progesterone receptor A levels. J Mol Endocrinol 31 2 (2003) 241-253
11. Fujimoto J., Sakaguchi H., Hirose R., and Tamaya T. Significance of sex steroids in roles of cadherin subfamily and its related proteins in the uterine endometrium and placenta. Horm Res 50 (1998) 30-36
12. Chabbert-Buffet N., Meduri G., Bouchard P., and Spitz I.M. Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications. Hum Reprod Update 11 3 (2005) 293-307
13. Beral V. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362 9382 (2003) 419-427
14. Carnevale R.P., Proietti C.J., Salatino M., Urtreger A., Peluffo G., Edwards D.P., et al. Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways. Mol Endocrinol 21 6 (2007) 1335-1358
15. Kublickiene K., Fu X.D., Svedas E., Landgren B.M., Genazzani A.R., and Simoncini T. Effects in postmenopausal women of estradiol and medroxyprogesterone alone and combined on resistance artery function and endothelial morphology and movement. J Clin Endocrinol Metab 93 5 (2008) 1874-1883
16. Moore M.R., Conover J.L., and Franks K.M. Progestin effects on long-term growth, death, and Bcl-xL in breast cancer cells. Biochem Biophys Res Commun 277 (2000) 650-665
17. Pike M.C., Spicer D.V., Dahmoush L., and Press M.F. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15 1 (1993) 17-35
18. Groshong S.D., Owen G.I., Grimison B., Schauer I.E., Todd M.C., Langan T.A., et al. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Mol Endocrinol 11 11 (1997) 1593-1607
19. Kandouz M., Lombet A., Perrot J.Y., Jacob D., Carvajal S., Kazem A., et al. Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells. J Steroid Biochem Mol Biol 69 1-6 (1999) 463-471
20. Migliaccio A., Piccolo D., Castoria G., Di Domenico M., Bilancio A., Lombardi M., et al. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J 17 7 (1998) 2008-2018
21. Ballaré C., Uhrig M., Bechtold T., Sancho E., Di Domenico M., Migliaccio A., et al. Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the cSrc/Erk pathway in mammalian cells. Mol Cell Biol 23 (2003) 1994-2008
22. Rosenblatt J. Mitosis: moesin and the importance of being round. Curr Biol 18 7 (2008) R292-R293
23. Maddox A.S., and Burridge K. RhoA is required for cortical retraction and rigidity during mitotic cell rounding. J Cell Biol 160 (2003) 255-265
24. Sherr C.J. Cancer cell cycles. Science 274 (1996) 1672-1677
25. Skildum A., Faivre E., and Lange C.A. Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases. Mol Endocrinol 19 2 (2005) 327-339
26. Li L., Backer J., Wong A.S., Schwanke E.L., Stewart B.G., and Pasdar M. Bcl-2 expression decreases cadherin-mediated cell-cell adhesion. J Cell Sci 116 Pt 18 (2003) 3687-3700
27. Qian X, Karpova T, Sheppard AM, McNally J, Lowy DR. E-cadherin-mediated adhesion inhibits liganddependent activation of diverse receptor tyrosine kinases. EMBO J 2004;21;23(8):1739-48.
28. Murphy L.J., Sutherland R.L., Stead B., Murphy L.C., and Lazarus L. Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells. Cancer Res 46 2 (1986) 728-734
29. Percival J.M., Thomas G., Cock T.A., Gardiner E.M., Jeffrey P.L., Lin J.J., et al. Sorting of tropomyosin isoforms in synchronised NIH 3T3 fibroblasts: evidence for distinct microfilament populations. Cell Motil Cytoskeleton 47 3 (2000) 189-208
30. Altucci L., Addeo R., Cicatiello L., Dauvois S., Parker M.G., Truss M., et al. 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene 12 (1996) 2315-2324
31. Saitoh M., Ohmichi M., Takahashi K., Kawagoe J., Ohta T., Doshida M., et al. Medroxyprogesterone acetate (MPA) induces cell proliferation through up-regulation of cyclin D1 expression via phosphatidylinositol 3-kinase/Akt/nuclear factor-kappaB cascade in human breast cancer cells. Endocrinology 146 11 (2005) 4917-4925
32. Lydon J.P., DeMayo F.J., Funk C.R., Mani S.K., Hughes A.R., Montgomery C.A., et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 9 (1995) 2266-2278
33. Olsson H., Jernstrom H., Alm P., Kreipe H., Ingvar C., Jonsson P.E., et al. Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors. Breast Cancer Res Treat 40 (1996) 187-196
34. Aupperlee M.D., Smith K.T., Kariagina A., and Haslam S.Z. Progesterone receptor isoforms A and B: temporal and spatial differences in expression during murine mammary gland development. Endocrinology 146 (2005) 3577-3588
35. Levin E.R. Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor. Mol Endocrinol 17 3 (2003) 309-317
36. Blaschuk O.W., Munro S.B., Farookhi R., and E-cadherin. estrogens and cancer: is there a connection?. Can J Oncol 4 4 (1994) 291-301
37. Huang S., and Ingber D.E. Shape-dependent control of cell growth, differentiation, and apoptosis: switching between attractors in cell regulatory networks. Exp Cell Res 261 1 (2000) 91-103
38. Malaguti C., and Rossini G.P. Recovery of cellular E-cadherin precedes replenishment of estrogen receptor and estrogen-dependent proliferation of breast cancer cells rescued from a death stimulus. J Cell Physiol 192 2 (2002) 171-181
39. Piercy K.T., Donnell R.L., Kirkpatrick S.S., Timaran C.H., Stevens S.L., Freeman M.B., et al. Effects of estrogen, progesterone, and combination exposure on interleukin-1 beta-induced expression of VCAM-1, ICAM-1, PECAM, and E-selectin by human female iliac artery endothelial cells. J Surg Res 105 2 (2002) 215-219
40. Wakatsuki A., Okatani Y., Ikenoue N., and Fukaya T. Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen. Circulation 105 12 (2002) 1436-1439
41. Guarino M. Epithelial-mesenchymal transition and tumour invasion. Int J Biochem Cell Biol 39 12 (2007) 2153-2160
42. Zhang W., and Robinson D.N. Balance of actively generated contractile and resistive forces controls cytokinesis dynamics. Proc Natl Acad Sci USA 102 (2005) 7186-7191
43. Zhao S., Chen X., Lu X., Yu Y., and Feng Y. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma. Gynecol Oncol 105 1 (2007) 45-54
44. Faivre E.J., and Lange C.A. Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells. Mol Cell Biol 27 2 (2007) 466-480
45. Lin J.C., and Tarn W.Y. Exon selection in alpha-tropomyosin mRNA is regulated by the antagonistic action of RBM4 and PTB. Mol Cell Biol 25 22 (2005) 10111-10121
46. Razandi M., Pedram A., Rosen E.M., and Levin E.R. BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer. Mol Cell Biol 24 13 (2004) 5900-5913